FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Catalyst Pharmaceuticals Announces Launch of Expanded Access Program Website and Participation at the American Association of Neuromuscular & Electrodiagnostic Medicine Conference
September 14, 2016
Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 18th Annual Global Investment Conference
September 08, 2016
Catalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia Gravis
September 02, 2016
Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update
August 09, 2016
Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 10th, 2016
August 01, 2016
Catalyst Pharmaceuticals Announces Agreement with FDA on Confirmatory Phase 3 Study Protocol for Firdapse in Lambert-Eaton Myasthenic Syndrome
June 13, 2016
Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
June 10, 2016
from PR Newswire
BRIEF-Catalyst Pharmaceuticals' board entered into amendment no. 1 to rights agreement
September 20, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here